Login
← Go Back
Astrazeneca Pharma India
ASTRAZEN · Pharma > Pharmaceuticals & Drugs · Chairman: Narayan K Seshadri · MD: Gagandeep Singh Bedi · Listing date: July 29, 1998 · Employees: 1283 · Bangalore · http://www.astrazeneca.in
Stock Price vs Company Growth
1d
0.1%
1w
1.6%
1m
-0.0%
3m
5.3%
6m
2.6%
1y
37.8%
5y
18.7%
10y
23.3%
all
14.6%
🤔 How to analyze this graph?
Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price
₹ 6,497 0.1%
6,222
8,140
Company Overview
Sales
1,485 Cr
Growth: 26.0%
Profit after Tax
81.9 Cr
Growth: 3.1%
Mid Cap
16,242 Cr
P/E: 198.3x
Industry P/E: 37.3x
Fundamentals
Sales (Cr) ₹ 1,485
Growth 26.0%
EBITDA 10.4%
P/S 10.9x
Dividend 0.4%
P/E 198.3x
Book Value ₹ 295
PEG Ratio 7.6x
ROE 11.5%
P/B 22.0x
Shareholding Pattern
Institutions
Promoters
Astrazeneca Pharmaceuticals Ab
75.0 %
Others
Tejas Bhalchandra Trivedi
2.67 %
Shivani T. Trivedi
1.98 %
Minaxi Bhalchandra Trivedi
1.84 %
Iepf
0.46 %
Increase    Decrease    No change
Company Profile Detailed
The Company is engaged in the business of manufacture, distribution and marketing of life-changing medicines in crucial areas of healthcare including oncology, cardiovascular, diabetes, renal, metabolic and respiratory.Core Therapy AreasCardiovascularOncologyRespiratoryMilestones and achievements1979: Astra IDL formation.1982: Astra factory foundation.1992: Launch of Cerviprime, Plendil, Ramace, Rhinocort and Imdur.
Belongs to (17 Indices) view more
Investors (43)
shivani....
merrill....
ishares....
Followers (3)
nitin2
keerthi
deepak